branchenspezifische Dividenden PharmaCorp Rx Inc.
Aktien
A40EX7
CA71714X1050
PCRX
Handel - Medikamente
|
Markt geschlossen -
Toronto S.E.
21:13:00 28.08.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 0.4900 CAD | +0.51% |
|
-2.00% | +7.69% |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 49x | - | 1.82x | 22.63x | 53.09x | 61.39 Mio. | |
| -.--% | -.--% | 16.78x | 1.51x | 0.68x | 10.1x | 10.99x | 14.92 Mrd. | |
| 1.07% | 1.33% | 20.98x | 2.36x | 0.8x | 13.48x | 13.73x | 6.48 Mrd. | |
| 2.19% | 2.51% | 16.99x | 1.75x | 0.77x | 7.98x | 10.01x | 6.45 Mrd. | |
| 3.26% | 3.35% | 14.75x | 2.17x | 0.95x | 7.07x | 8.67x | 4.12 Mrd. | |
| 5.51% | 6.05% | 14.61x | 4.42x | 1.25x | 7.66x | 14.37x | 3.25 Mrd. | |
| 5.23% | 5.78% | 13.86x | 2.63x | 0.58x | 4.77x | 7.48x | 3.07 Mrd. | |
| 4.64% | 5.09% | 13.83x | 6.26x | 0.83x | 6.24x | 8.68x | 2.91 Mrd. | |
| 2% | 2.43% | 20.51x | 3.59x | 0.6x | 7.65x | 12.52x | 1.53 Mrd. | |
| 0.02% | -.--% | -131.05x | 2.72x | 0.45x | 16.1x | 69.56x | 1.52 Mrd. | |
| 3.32% | 4.53% | 13.91x | 0.87x | 0.29x | 3.09x | 6.73x | 960 Mio. | |
| 5.84% | 5.85% | 18.23x | 2.2x | 0.83x | 7.58x | 17.88x | 883 Mio. | |
| 1.31% | 1.9% | 27.32x | 7.45x | 0.99x | 13.48x | 20.89x | 829 Mio. | |
| Durchschnitt | 2.87% | 3.23% | 8.44x | 3.16x | 0.83x | 9.83x | 19.58x | 3.62 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 2.01% | 2.25% | 12.23x | 2.50x | 0.77x | 9.25x | 13.10x |
- Börse
- Aktien
- A40EX7 Aktie
- Sektor PharmaCorp Rx Inc.
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
